Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Presentations
Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test
World Veterinary Cancer Congress 2020
Learn More →
Presentations
From dog to human: precision medicine for comparative oncology
Precision Medicine World Conference 2020
Learn More →
Video/Podcast Interviews
Interview with Sungwon Lim: Founder & CEO of ImpriMed
Entrepreneurship, Interviews, Level Up!
Learn More →
Presentations
ImpriMed: precision medicine for pet cancer care
NYC Oncology Conference 2019
Learn More →
Presentations
Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test
Veterinary Cancer Society Annual Conference 2019
Learn More →
Press Releases
ImpriMed Raises $4M for Customized Cancer Treatments for Dogs
GlobeNewswire
Learn More →
In the News
At Pear demo day, a who’s who of VCs, and plenty of fresh ideas
TechCrunch
Learn More →
Previous
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
